Tower Research Capital LLC (TRC) - ASLAN PHARMACEUTICALS LTD ownership

ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 35 filers reported holding ASLAN PHARMACEUTICALS LTD in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ASLAN PHARMACEUTICALS LTD
ValueSharesWeighting
Q4 2021$0
-100.0%
200
-80.8%
0.00%
Q3 2021$2,000
+100.0%
1,041
+298.9%
0.00%
Q2 2019$1,0002610.00%
Other shareholders
ASLAN PHARMACEUTICALS LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,270,758$2,262,0000.72%
MANGROVE PARTNERS IM, LLC 2,514,576$4,476,0000.40%
TANG CAPITAL MANAGEMENT LLC 975,305$1,736,0000.36%
DAFNA Capital Management LLC 732,500$1,304,0000.35%
KNOTT DAVID M 478,186$851,0000.31%
Vivo Capital, LLC 2,840,909$5,057,0000.23%
SABBY MANAGEMENT, LLC 688,400$1,225,0000.17%
MYDA Advisors LLC 236,165$420,0000.12%
Affinity Asset Advisors, LLC 250,000$445,0000.11%
RTW INVESTMENTS, LP 3,250,000$5,785,0000.09%
View complete list of ASLAN PHARMACEUTICALS LTD shareholders